The concept of the ovarian continuum can be understood as a process that occurs during a woman's lifetime and begins during intrauterine life with fertilization. Women start their reproductive years with approximately five hundred thousand follicles containing oocytes, of which only around five hundred will be released during ovulation. Ovulation has been recognized as an event linked with reproduction; however, recent evidence supports the role of ovulation as a sign of health. The use of biomarkers that help women recognize ovulation enables them to identify their health status. This knowledge helps medical healthcare providers in the prevention, diagnosis, and treatment of different pathologies related with endocrine disorders, gynecological abnormalities, autoimmune, genetic, and neoplastic diseases, as well as pregnancy-related issues. The knowledge of the ovarian continuum and the use of biomarkers to recognize ovulation should be considered a powerful tool for women and medical professionals.
Summary
The ovarian continuum is a process that occurs during a woman's lifetime. It begins during intrauterine life with fertilization and ends with menopause. This process can be greatly affected by different conditions such as changes in hormonal levels and illnesses. Therefore, understanding and promoting the knowledge and use of biomarkers of ovulation in women is a key aspect to consider when evaluating their health status. The knowledge and education about the ovarian continuum should be taken into account as a powerful tool for women and medical professionals.
AmerS.2009. Polycystic ovarian syndrome: Diagnosis and management of related infertility. Obstetrics, Gynaecology and Reproductive Medicine19: 263–70.
2.
Araujo-LopesR., CramptonJ.R., AquinoN.S., MirandaR.M., KokayI.C., ReisA.M., FranciC.R., GrattanD.R., and SzawkaR.E.2014. Prolactin regulates kisspeptin neurons in the arcuate nucleus to suppress LH secretion in female rats. Endocrinology155: 1010–20.
3.
BarronM.L.2004. Proactive management of menstrual cycle abnormalities in young women. Journal of Perinatal and Neonatal Nursing18: 81–92.
4.
BillingsE.L., BrownJ.B., BillingsJ.J., and BurgerH.G.1972. Symptoms and hormonal changes accompanying ovulation. Lancet1: 282–84.
5.
BlackwellL.F., BrownJ.B.VigilP.GrossB.SufiS., and d'ArcanguesC.2003. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay. Steroids68: 465–76.
6.
BlackwellL.F., VigilP.CookeD.G., d'ArcanguesC., and BrownJ.B.2013. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: Variability of normal menstrual cycle profiles. Human Reproduction28: 3306–15.
7.
BlockE.1952. Quantitative morphological investigations of the follicular system in women; Variations at different ages. Acta Anatomica (Basel)14: 108–23.
8.
BrownJ.B.2011. Types of ovarian activity in women and their significance: The continuum (a reinterpretation of early findings). Human Reproduction Update17: 141–58.
9.
BrownS., BlackwellL., and CookeD.2017. Online fertility monitoring: Some of the issues. International Journal of Open Information Technologies5: 85–91.
10.
ChretienF.C., and DuboisR.1991. Effect of nomegestrol acetate on spinability, ferning and mesh dimension of midcycle cervical mucus. Contraception43: 55–65.
11.
ClarkeH., DhilloW.S., and JayasenaC.N.2015. Comprehensive review on kisspeptin and its role in reproductive disorders. Endocrinology & Metabolism (Seoul)30: 124–41.
12.
CortésM.E., CarreraB., RiosecoH., del RioJ.P., and VigilP.2015. The role of Kisspeptin in the onset of puberty and in the ovulatory mechanism: A mini-review. Journal of Pediatric Adolescent Gynecology28: 286–91.
13.
Diamanti-KandarakisE.2006. Insulin resistance in PCOS. Endocrine30: 13–17.
DuaneM., ContrerasA., JensenE.T., and WhiteA.2016. The performance of fertility awareness-based method apps marketed to avoid pregnancy. Journal of the American Board of Family Medicine29: 508–11.
16.
EliasC.F., AschkenasiC., LeeC., KellyJ., AhimaR.S., BjorbaekC., FlierJ.S., SaperC.B., and ElmquistJ.K.1999. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron23: 775–86.
17.
ErichsenM.M., HusebyeE.S., MichelsenT.M., DahlA.A., and LovasK.2010. Sexuality and fertility in women with Addison's disease. Journal of Clinical Endocrinology & Metabolism95: 4354–60.
18.
ErichsenM.M., LovasK., SkinningsrudB., WolffA.B., UndlienD.E., SvartbergJ., FougnerK.J., 2009. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: Observations from a Norwegian registry. Journal of Clinical Endocrinology & Metabolism94: 4882–90.
19.
FauserB.C., TarlatzisB.C., RebarR.W., LegroR.S., BalenA.H., LoboR., CarminaE., 2012. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility97: 28–38 e25.
20.
FerinM., Van VugtD., and WardlawS.1984. The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Recent Progress in Hormone Research40: 441–85.
21.
FraserI.S., CritchleyH.O., MunroM.G., and BroderM.2007. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?Human Reproduction22: 635–43.
22.
GleicherN., KimA., WeghoferA., KushnirV.A., Shohat-TalA., LazzaroniE., LeeH.J., and BaradD.H.2013. Hypoandrogenism in association with diminished functional ovarian reserve. Human Reproduction28: 1084–91.
23.
HarlowS.D., GassM., HallJ.E., LoboR., MakiP., RebarR.W., ShermanS., SlussP.M., de VilliersT.J., and GroupStraw Collaborative. 2012. Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. Menopause19: 387–95.
24.
HawkinsS.M., and MatzukM.M.2008. The menstrual cycle: Basic biology.Annals of the New York Academy of Science1135: 10–18.
25.
HiguchiK., NawataH., MakiT., HigashizimaM., KatoK., and IbayashiH.1984. Prolactin has a direct effect on adrenal androgen secretion. Journal of Clinical Endocrinology & Metabolism59: 714–18.
26.
IraniM., and MerhiZ.2014. Role of vitamin D in ovarian physiology and its implication in reproduction: A systematic review. Fertility & Sterility 102: 460–68e3.
27.
JohanssonG.G., KaronenS.L., and LaaksoM.L.1983. Reversal of an elevated plasma level of prolactin during prolonged psychological stress. Acta Physiologica Scandinavica119: 463–64.
28.
JukicA.M., WeinbergC.R., WilcoxA.J., McConnaugheyD.R., HornsbyP., and BairdD.D.2008. Accuracy of reporting of menstrual cycle length. American Journal of Epidemiology167: 25–33.
29.
KlausH., and MartinJ.L.1989. Recognition of ovulatory/anovulatory cycle pattern in adolescents by mucus self-detection. Journal of Adolescent Health Care10: 93–96.
30.
KoikeK., MiyakeA., AonoT., SakumotoT., OhmichiM., YamaguchiM., and TanizawaO.1991. Effect of prolactin on the secretion of hypothalamic GnRH and pituitary gonadotropins. Hormone Research35, Suppl 1: 5–12.
31.
KolstadH.A., BondeJ.P., HjollundN.H., JensenT.K., HenriksenT.B., ErnstE., GiwercmanA., SkakkebaekN.E., and OlsenJ.1999. Menstrual cycle pattern and fertility: A prospective follow-up study of pregnancy and early embryonal loss in 295 couples who were planning their first pregnancy. Fertility & Sterility71: 490–96.
32.
KrasnowJ.S., HickeyG.J., and RichardsJ.S.1990. Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Molecular Endocrinology4: 13–21.
33.
KrassasG.E., PontikidesN., KaltsasT., PapadopoulouP., and BatrinosM.1994. Menstrual disturbances in thyrotoxicosis. Clinical Endocrinology (Oxf)40: 641–44.
34.
KrassasG.E., PontikidesN., KaltsasT., PapadopoulouP., PaunkovicJ., PaunkovicN., and DuntasL.H.1999. Disturbances of menstruation in hypothyroidism. Clinical Endocrinology (Oxf)50: 655–59.
35.
LavenJ.S., and FauserB.C.2004. Inhibins and adult ovarian function. Molecular and Cellular Endocrinology225: 37–44.
36.
LerchbaumE., and Obermayer-PietschB.2012. Vitamin D and fertility: A systematic review. European Journal of Endocrinology166: 765–78.
37.
LoboR.2014. Menopause and aging. In Yen and Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. 7th ed., 325–356. Philadelphia: Elsevier/Saunders.
38.
LunenfeldB., and InslerV.1993. Follicular development and its control. Gynecology and Endocrinology7: 285–91.
39.
MalcolmC.E., and CummingD.C.2003. Does anovulation exist in eumenorrheic women?Obstetrics and Gynecology102: 317–18.
40.
MenárguezM., PastorL.M., and OdebladE.2003. Morphological characterization of different human cervical mucus types using light and scanning electron microscopy. Human Reproduction18: 1782–89.
41.
MerkeD.P., and BornsteinS.R.2005. Congenital adrenal hyperplasia. Lancet365: 2125–36.
42.
MiroF., and AspinallL.J.2005. The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle. Human Reproduction20: 96–100.
43.
MisaoR., NakanishiY., IwagakiS., FujimotoJ., and TamayaT.1998. Expression of progesterone receptor isoforms in corpora lutea of human subjects: Correlation with serum oestrogen and progesterone concentrations. Molecular Human Reproduction4: 1045–52.
44.
MondalS., SahaI., DasS., GangulyA., DasD., and TripathiS.K.2013. A new logical insight and putative mechanism behind fluoxetine-induced amenorrhea, hyperprolactinemia and galactorrhea in a case series. Therapeutic Advances in Psychopharmacology3: 322–34.
45.
MottaP.M., MakabeS., and NottolaS.A.1997. The ultrastructure of human reproduction. I. The natural history of the female germ cell: Origin, migration and differentiation inside the developing ovary. Human Reproduction Update3: 281–95.
46.
Nader, S. 2000. Case Studies in Reproductive Endocrinology. London: Arnold.
47.
NassarallaC.L., StanfordJ.B., DalyK.D., SchneiderM., SchliepK.C., and FehringR.J.2011. Characteristics of the menstrual cycle after discontinuation of oral contraceptives. Journal of Womens Health (Larchmt)20: 169–77.
48.
NewM.I.2004. An update of congenital adrenal hyperplasia. Annals of the New York Academy of Science1038: 14–43.
49.
OrbachH., and ShoenfeldY.2007. Hyperprolactinemia and autoimmune diseases. Autoimmunity Reviews6: 537–42.
50.
PauliJ.M., Raja-KhanN., WuX., and LegroR.S.2011. Current perspectives of insulin resistance and polycystic ovary syndrome. Diabetic Medicine28: 1445–54.
51.
PetersH., ByskovA.G., and GrinstedJ.1978. Follicular growth in fetal and prepubertal ovaries of humans and other primates. Clinics in Endocrinology and Metabolism7: 469–85.
52.
PopatV.B., ProdanovT., CalisK.A., and NelsonL.M.2008. The menstrual cycle: A biological marker of general health in adolescents. Annals of the New York Academy of Science1135: 43–51.
53.
PoppeK., VelkeniersB., and GlinoerD.2007. Thyroid disease and female reproduction. Clinical Endocrinology (Oxf)66: 309–21.
54.
PriorJ.C., NaessM., LanghammerA., and ForsmoS.2015. Ovulation prevalence in women with spontaneous normal-length menstrual cycles - A population-based cohort from HUNT3, Norway. PLoS One10: e0134473.
55.
RanasinhaS., JohamA.E., NormanR.J., ShawJ.E., ZoungasS., BoyleJ., MoranL., and TeedeH.J.2015. The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: A statistical modelling approach. Clinical Endocrinology (Oxf)83: 879–87.
56.
RoccaW.A., GrossardtB.R., MillerV.M., ShusterL.T., and BrownR.D.Jr.2012. Premature menopause or early menopause and risk of ischemic stroke. Menopause19: 272–77.
57.
SahuA.2002. Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones. Journal of Neuroendocrinology14: 796–804.
58.
SaketosM., SharmaN., and SantoroN.F.1993. Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biology of Reproduction49: 1270–1276.
59.
ShusterL.T., RhodesD.J., GostoutB.S., GrossardtB. R., and RoccaW.A.2010. Premature menopause or early menopause: long-term health consequences. Maturitas65: 161–6.
60.
SkinnerM.K.2005. Regulation of primordial follicle assembly and development. Human Reproduction Update11: 461–71.
61.
StanhopeR., and BrookC.G.1986. Clinical diagnosis of disorders of puberty. British Journal of Hospital Medicine35: 57–58.
62.
StoufferR.L.2003. Progesterone as a mediator of gonadotrophin action in the corpus luteum: Beyond steroidogenesis. Human Reproduction Update9: 99–117.
63.
SvejmeO., AhlborgH.G., NilssonJ.A., and KarlssonM.K.2012. Early menopause and risk of osteoporosis, fracture and mortality: A 34-year prospective observational study in 390 women. BJOG: An International Journal of Obstetrics and Gynaecology119: 810–16.
64.
UnuaneD., TournayeH., VelkeniersB., and PoppeK.2011. Endocrine disorders & female infertility. Best Practice & Research: Clinical Endocrinology & Metabolism25: 861–73.
65.
van HooffM.H., VoorhorstF.J., KapteinM.B., HirasingR.A., KoppenaalC., and SchoemakerJ.2004. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Human Reproduction19: 383–92.
66.
VigilP.2004. La fertilidad de la pareja humana. 3. ed, Lecciones. Santiago, Chile: Ediciones Universidad Católica de Chile.
67.
VigilP., BlackwellL., and CortesM.E.2012. The Importance of Fertility Awareness in the Assessment of a Woman's Health. Linacre Quarterly4: 426–450.
68.
VigilP., CericF., CortesM.E., and KlausH.2006. Usefulness of monitoring fertility from menarche. Journal of Pediatric Adolescent Gynecology19: 173–79.
69.
VigilP., ContrerasP., AlvaradoJ.L., GodoyA., SalgadoA.M., and CortesM.E.2007. Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. Human Reproduction22: 2974–80.
70.
VigilP., CortésM.E., ZunigaA., RiquelmeJ., and CericF.2009. Scanning electron and light microscopy study of the cervical mucus in women with polycystic ovary syndrome. Journal of Electron Microscopy (Tokyo)58: 21–27.
71.
VigilP., CroxattoH., and CortésM.E.2014. Ciclo menstrual. In Ginecologia. Edited by SanchezAlfredo Perez, 4 ed.Santiago: Mediterraneo.
72.
VigilP., del RíoM., SocíasM., GonzálezA., and HoneymanJ.2007. Cellular immunity alterations in hyperprolactinemia. Acta Cytologica51: 2.
73.
VigilP., OrellanaR., del RíoM., and CortésM.2008. Educación en afectividad y sexualidad para adolescentes: Resultados de la implementación del programa teen STAR. Ars Médica17: 19.
74.
VigilP., Rodríguez-RigauL., PalaciosX., KauakS., and MoralesP.1993. Diagnosis of menstrual disorders in adolescence. In Reproductive Medicine. Edited by FrajeseG., SteinbergerE., and Rodríguez-RigauL.J., 149–54. New York: Raven Press.
